Clinical Trial Update: Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants [Phase 3]

View source ↗

Summary

Phase 3 study assessing the immunogenicity and safety of a booster dose of the DTaP-IPV-HB-PRP~T combined vaccine in healthy Turkish infants; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Pertussis
• Poliomyelitis

Drugs mentioned

• DTaP-IPV-HB-PRP~T Combined Vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Polio | Phase 3 | Status: COMPLETED | Results posted: 2014-04-03